• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-PSMD9

PSMD9 Monoclonal Antibody for WB, IF/ICC, FC (Intra), Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat, souris

Applications

WB, IF/ICC, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1H2G1

N° de cat : 67338-1-PBS

Synonymes

1H2G1, 26S proteasome non-ATPase regulatory subunit 9, p27, Rpn4



Informations sur le produit

67338-1-PBS cible PSMD9 dans les applications de WB, IF/ICC, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène PSMD9 Protéine recombinante Ag25654
Nom complet proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
Masse moléculaire calculée 27 kDa
Poids moléculaire observé 25-30 kDa
Numéro d’acquisition GenBankBC004213
Symbole du gène PSMD9
Identification du gène (NCBI) 5715
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

PSMD9 is a ubiquitous protein of eukaryotic cells and is a chaperon of the 26S proteasome complex, which degrades ubiquitinated proteins in eukaryotic cells and contributes to the degradation of intracellular proteins into antigenic peptides for antigen presentation by MHC class I cells. The 26S mammalian base sub-complex involves three distinct modules which have ATPase subunits distinctly associated to three chaperones, one of which is PSMD9 regulating the modules assembly. The PSMD9 ubiquitous regulatory role within the proteasome implies its potential pleiotropic effects within different physio-pathological systems. PSMD9 is known to form a stable subcomplex with PSMC3 and PSMC6, two of the AAA-ATPases, assisting in the assembly of the 20S and 19S particles to form the holo complex.

{{ptg:RelatedPrimaryAntibodies}}